Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Getinge AB
  6. News
  7. Summary
    GETI B   SE0000202624

GETINGE AB

(GETI B)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 11/26 11:29:53 am
385.2 SEK   +1.90%
11/26Elanders Nominates New Chairman for April 2022 Election
MT
11/24GETINGE : His life was saved by an incidental finding
PU
11/22GETINGE : Information package
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Getinge AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

10/20/2021 | 02:00am EST

Getinge AB reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 6,306 million compared to SEK 7,976 million a year ago. Net income was SEK 757 million compared to SEK 1,380 million a year ago. Basic earnings per share from continuing operations was SEK 2.78 compared to SEK 5.07 a year ago. For the nine months, sales was SEK 19,061 million compared to SEK 20,980 million a year ago. Net income was SEK 2,198 million compared to SEK 2,145 million a year ago. Basic earnings per share from continuing operations was SEK 8.07 compared to SEK 7.88 a year ago.


ę S&P Capital IQ 2021
All news about GETINGE AB
11/26Elanders Nominates New Chairman for April 2022 Election
MT
11/24GETINGE : His life was saved by an incidental finding
PU
11/22GETINGE : Information package
PU
11/22Medical kit maker Getinge raises targets, citing COVID impact
RE
11/22Getinge accelerates growth and productivity to reach new financial targets
AQ
11/19GETINGE : New innovative trial set out to bring urgent hope to women with ovarian cancer
PU
11/12“Life science means everything”
PU
11/12GETINGE AB (OM : GETI B) acquired Verrix, LLC.
CI
11/04Saving lives at Wythenshawe Hospital
PU
10/27Getinge's HL 40 heart-lung machine performed flawlessly during a complex first procedur..
PU
More news
Analyst Recommendations on GETINGE AB
More recommendations
Financials
Sales 2021 27 421 M 2 996 M 2 996 M
Net income 2021 3 153 M 345 M 345 M
Net Debt 2021 3 941 M 431 M 431 M
P/E ratio 2021 33,0x
Yield 2021 0,88%
Capitalization 105 B 11 520 M 11 463 M
EV / Sales 2021 3,97x
EV / Sales 2022 3,66x
Nbr of Employees 10 667
Free-Float 79,8%
Chart GETINGE AB
Duration : Period :
Getinge AB Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GETINGE AB
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 385,20 SEK
Average target price 413,50 SEK
Spread / Average Target 7,35%
EPS Revisions
Managers and Directors
Mattias Sven Perjos President, Chief Executive Officer & Director
Lars Sandstr÷m Chief Financial Officer
Johan Malmquist Chairman
Anna Romberg Executive VP-Legal, Compliance & Governance
Johan Bygge Independent Director
Sector and Competitors
1st jan.Capi. (M$)
GETINGE AB100.52%11 520
MASIMO CORPORATION5.88%15 691
NOVOCURE LIMITED-43.94%10 072
PENUMBRA, INC.42.95%9 346
SHOCKWAVE MEDICAL, INC.77.02%6 482
ASAHI INTECC CO., LTD.-29.67%6 345